BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 2 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2023. The put-call ratio across all filers is - and the average weighting 6.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $5,174,000 | -41.0% | 53,300 | -58.5% | 0.23% | -36.5% |
| Q1 2021 | $8,769,000 | +23.1% | 128,300 | +54.4% | 0.36% | +18.7% |
| Q4 2020 | $7,123,000 | +29.5% | 83,100 | -1.8% | 0.30% | +11.7% |
| Q3 2020 | $5,500,000 | -11.1% | 84,600 | 0.0% | 0.27% | -31.6% |
| Q2 2020 | $6,185,000 | +236.0% | 84,600 | +56.4% | 0.40% | +224.4% |
| Q1 2020 | $1,841,000 | -5.8% | 54,100 | +50.7% | 0.12% | -2.4% |
| Q4 2019 | $1,954,000 | +30.4% | 35,900 | 0.0% | 0.13% | -51.0% |
| Q3 2019 | $1,498,000 | – | 35,900 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |